Skip to main content

Medical Oncology

Ausgabe 11/2023

Inhalt (33 Artikel)

Original Paper

C2orf48 promotes the progression of nasopharyngeal carcinoma by regulating high mobility group AT-hook 2

Yanhui Jiang, Faya Liang, Renhui Chen, Yongsheng Huang, Zhiwen Xiao, Haicang Zeng, Ping Han, Xiaoming Huang

Original Paper

Toxicity evaluation of synthetic glucocorticoids against breast cancer cell lines MDA-MB-231, MCF-7 and human embryonic kidney HEK293

Dhouha Msalbi, Fatma Jellali, Jihene Elloumi-Mseddi, Bochra Hakim, Emna Sahli, Sami Aifa

Original Paper

Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals

Arash Letafati, Sayed-Hamidreza Mozhgani, Arezoo Marjani, Abdollah Amiri, Zeinab Siami, Mahdi Mohammaditabar, Ghazale Molaverdi, Mojtaba Hedayatyaghoobi

Original Paper

Diosmetin induces apoptosis and protective autophagy in human gastric cancer HGC-27 cells via the PI3K/Akt/FoxO1 and MAPK/JNK pathways

Zhaobin Pan, Zhiming Tan, Hongyan Li, Yang Wang, Haiyan Du, Jinhui Sun, Chunchao Li, Shicai Ye, Xin Li, Juanhua Quan

Original Paper

Colorectal cancer cell membrane biomimetic ferroferric oxide nanomaterials for homologous bio-imaging and chemotherapy application

Jun Li, Chenyu Lin, Yuqian Zhu, Chengwei Shao, Tiegong Wang, Bingdi Chen

Original Paper

HDAC11 mediates the ubiquitin-dependent degradation of p53 and inhibits the anti-leukemia effect of PD0166285

Ziwei Zhou, Liang Zhong, Xuan Chu, Peng Wan, Wenran Dan, Xin Shao, Shuyu Chen, Zhonghui Zhang, Yang Lu, Beizhong Liu

Original Paper

Identification of novel inhibitors from Urtica spp against TNBC targeting JAK2 receptor for breast cancer therapy

Shobha Upreti, Kartik Muduli, Jagannath Pradhan, Selvakumar Elangovan, Mukesh Samant

Open Access Original Paper

Whole-exome sequencing reveals mutational profiles of anorectal and gynecological melanoma

Wei Sun, Kunyan Liu, Hongyu Zhou, Fang Zhao, Yan Dong, Yu Xu, Yunyi Kong, Minghe Wang, Xi Cheng, Yong Chen

Original Paper

Combretastatin A-4 suppresses the invasive and metastatic behavior of glioma cells and induces apoptosis in them: in-vitro study

Mostafa Karimi Roshan, Amir R. Afshari, Farshad Mirzavi, Seyed Hadi Mousavi, Mohammad Soukhtanloo

Original Paper

Tamoxifen induces eryptosis through calcium accumulation and oxidative stress

Mohammad A. Alfhili, Abdulaziz M. Alyousef, Jawaher Alsughayyir

Original Paper

Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\GBSA and MD simulation study

Mohammed Ali Alshehri, Saeed Ahmed Asiri, Abdulrahman Alzahrani, Reem S. Alazragi, Leena S. Alqahtani, Amany I. Alqosaibi, Mashael M. Alnamshan, Qamre Alam, Misbahuddin M. Rafeeq

Review Article

How gallic acid regulates molecular signaling: role in cancer drug resistance

Samira Hassani, Fahimeh Ghanbari, Marzieh Lotfi, Waqas Alam, Michael Aschner, Jelena Popović-Djordjević, Seyed Hossein Shahcheraghi, Haroon Khan

Review Article

Solanum nigrum Linn.: Advances in anti-cancer activity and mechanism in digestive system tumors

Hongyu Pei, Jing Yang, Wang Li, Xing Luo, Yi Xu, Xueying Sun, Qian Chen, Qi Zhao, Li Hou, Gang Tan, Daolin Ji

Review Article

Involving stemness factors to improve CAR T-cell-based cancer immunotherapy

Sara Abdalrazzaq M. Noraldeen, Irodakhon Rasulova, Repudi Lalitha, Farah Hussin, Hashem O. Alsaab, Ahmed Hussien Alawadi, Ali Alsaalamy, Nidhal Hassan Sayyid, Adnan Taan Alkhafaji, Yasser Fakri Mustafa, Sepideh Karkon Shayan

Review Article

Himalayan flora: targeting various molecular pathways in lung cancer

Abija James, K. Akash, Avinash Sharma, Sanjib Bhattacharyya, Pornsak Sriamornsak, Rupak Nagraik, Deepak Kumar

Review Article

Theranostic signature of tumor-derived exosomes in cancer

Samruti Kumar, Rajib Dhar, Lokesh Babu Sirkali Suresh Kumar, Gauresh Gurudas Shivji, Rama Jayaraj, Arikketh Devi

Review Article

Novel biomolecules in targeted cancer therapy: a new approach towards precision medicine

Sandra Kannampuzha, Reshma Murali, Abilash Valsala Gopalakrishnan, Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Arunraj Namachivayam, Alex George, Abhijit Dey, Balachandar Vellingiri

Review Article

Recent advancement in targeted therapy and role of emerging technologies to treat cancer

Shrikant Barot, Henis Patel, Anjali Yadav, Igor Ban

Review Article

Immunotherapies landscape and associated inhibitors for the treatment of cervical cancer

Agrima Yadav, Shikha Yadav, Md. Aftab Alam

Open Access Review Article

Roles of circRNAs in regulating the tumor microenvironment

Tao Liu, Kaijun Long, Zhengfeng Zhu, Yongxiang Song, Cheng Chen, Gang Xu, Xixian Ke

Review Article

Unveiling the genetic and epigenetic landscape of colorectal cancer: new insights into pathogenic pathways

Humzah Postwala, Yesha Shah, Priyajeet S. Parekh, Mehul R. Chorawala

Review Article

The roles of P-selectin in cancer cachexia

Tingting Ling, Jing Liu, Liang Dong, Ju Liu

Short Communication

Deregulation of cytokine affecting oral neutrophil subsets in oral cancer

Sudhansubala Lenka, Sanat Kumar Bhuyan, Ruchi Bhuyan

Open Access Letter to the Editor

Letter to editor: confusions about the role of RNF149 in apoptosis and PI3K/AKT signaling

Xiaobin Guo, Qian Yang, Hongxin Yang

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.